Search
01/11/2025
On the robustness of the Transit-Guided Radiation Therapy technique against variations in linac operating conditions
Latorre-Musoll, A, Serrano-Rueda, S, Jornet, N, Sempau, J. On the robustness of the Transit-Guided Radiation Therapy technique against variations in linac operating conditions. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2025; 139DOI:10.1016/j.ejmp.2025.105206. PMID:41135169. IF:2.700(Q2/4D).
01/09/2025
Reirradiation dose constraints in clinical practice: Results of an international survey
Stroom, J, Ayadi, M, Aarberg, A, Batel, V, Ceylan, C, Cleary, S, Greco, C, Hoffmann, L, Jackson, A, Kelly, C, Mayo, C, Michailidou, C, Murrell, DH, Muscat, S, Pagett, CJH, Paradis, KC, Perez-Alija, J, Yorke, E, Zaila, A, West, N. Reirradiation dose constraints in clinical practice: Results of an international survey. RADIOTHERAPY AND ONCOLOGY. 2025; 210DOI:10.1016/j.radonc.2025.111030. PMID:40669609. IF:5.300(Q1/2D).
01/09/2025
Repositioning Radiation Oncology at the centre of integrated oncology care: A manifesto of the European Society for Radiotherapy and Oncology (ESTRO)
Meattini, I, Aznar, MC, Boldrini, L, Borgmann, K, Clark, CH, Faivre-Finn, C, Forde, E, van der Heide, UA, Jereczek-Fossa, BA, Jornet, N, Kirby, AM, Ost, P, Ratosa, I, Tanderup, K, Troost, EGC, Cortese, AJ, Guckenberger, M. Repositioning Radiation Oncology at the centre of integrated oncology care: A manifesto of the European Society for Radiotherapy and Oncology (ESTRO). RADIOTHERAPY AND ONCOLOGY. 2025; 210DOI:10.1016/j.radonc.2025.111035. PMID:40659192. IF:5.300(Q1/2D).
01/08/2025
Cone beam CT dose optimisation: A review and expert consensus by the 2022 ESTRO Physics Workshop IGRT working group
Wilson, LJ, Hadjipanteli, A, Ostergaard, DE, Bogaert, E, Brown, KF, DeJong, R, Earley, J, Edouard, M, Khan, M, Lindsay, J, van der Himst, J, Ding, GX, Wood, T, Aznar, MC, Jornet, N, Ntentas, G. Cone beam CT dose optimisation: A review and expert consensus by the 2022 ESTRO Physics Workshop IGRT working group. RADIOTHERAPY AND ONCOLOGY. 2025; 209DOI:10.1016/j.radonc.2025.110958. PMID:40425073. IF:5.300(Q1/2D).